Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O

被引:8
作者
Bu, ZG [1 ]
Ye, L [1 ]
Skeen, MJ [1 ]
Ziegler, HK [1 ]
Compans, RW [1 ]
Yang, CL [1 ]
机构
[1] Emory Univ, Sch Med, Dept Microbiol & Immunol, Rollins Res Ctr, Atlanta, GA 30322 USA
关键词
D O I
10.1089/088922203765551755
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An effective vaccine against AIDS should induce both cellular and humoral immune responses. Here we report that immunization of mice with a DNA plasmid encoding a chimeric protein consisting of HIV89.6 Env gp140 and the listeriolysin O (LLO) C-terminal segment ( 59 amino acids) significantly enhanced both humoral and cellular immune responses against the HIV89.6 Env protein. Plasmid DNA expression vectors with genes codon-optimized for mammalian expression were synthesized for HIV89.6 gp140 as well as for chimeric protein gp140 - LLO, in which the coding sequence for the C-terminal 59 amino acids of LLO were fused in frame to the 39 end of the codon-optimized gene for gp140. All plasmid vectors produced high levels of protein expression, and the gp140 - LLO chimeric protein was cleaved and secreted as efficiently as gp140. Analysis of humoral immune responses by ELISA showed that the chimeric gp140 - LLO construct induced higher antibody responses than the gp140 construct in immunized mice, more notably in the IgG2a antibody subtype. Intracellular cytokine staining and flow cytometry analysis showed that the gp140 - LLO construct induced significantly higher levels of cytotoxic T lymphocyte immune responses against the HIV 89.6 Env protein than those observed with the gp140 construct. Our results thus demonstrate that the C-terminal segment of LLO can be effectively employed to enhance both cellular and humoral immune responses against the HIV89.6 Env antigen in the context of a DNA vaccine.
引用
收藏
页码:409 / 420
页数:12
相关论文
共 42 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]   Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys [J].
Barouch, DH ;
Craiu, A ;
Kuroda, MJ ;
Schmitz, JE ;
Zheng, XX ;
Santra, S ;
Frost, JD ;
Krivulka, GR ;
Lifton, MA ;
Crabbs, CL ;
Heidecker, G ;
Perry, HC ;
Davies, ME ;
Xie, H ;
Nickerson, CE ;
Steenbeke, TD ;
Lord, CI ;
Montefiori, DC ;
Strom, TB ;
Shiver, JW ;
Lewis, MG ;
Letvin, NL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4192-4197
[3]   Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes [J].
Barouch, DH ;
Kunstman, J ;
Kuroda, MJ ;
Schmitz, JE ;
Santra, S ;
Peyerl, FW ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Gorgone, DA ;
Montefiori, DC ;
Lewis, MG ;
Wolinsky, SM ;
Letvin, NL .
NATURE, 2002, 415 (6869) :335-339
[4]  
BRUNT LM, 1990, J IMMUNOL, V145, P3540
[5]   Endosomal proteolysis and MHC class II function [J].
Chapman, HA .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (01) :93-102
[6]   Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis [J].
Chattergoon, MA ;
Kim, JJ ;
Yang, JS ;
Robinson, TM ;
Lee, DJ ;
Dentchev, T ;
Wilson, DM ;
Ayyavoo, V ;
Weiner, DB .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :974-979
[7]   Impairment of CD4+ T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants [J].
Ciurea, A ;
Hunziker, L ;
Klenerman, P ;
Hengartner, H ;
Zinkernagel, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) :297-305
[8]   Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons [J].
Corbet, S ;
Vinner, L ;
Hougaard, DM ;
Bryder, K ;
Nielsen, HV ;
Nielsen, C ;
Fomsgaard, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (18) :1997-2008
[9]   CD4+ HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE-SPECIFIC CYTOTOXIC LYMPHOCYTES-T DERIVED FROM THE PERIPHERAL-BLOOD CELLS OF AN HIV-1-INFECTED INDIVIDUAL [J].
CURIEL, TJ ;
WONG, JT ;
GORCZYCA, PF ;
SCHOOLEY, RT ;
WALKER, BD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (01) :61-68
[10]   Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein [J].
Deml, L ;
Bojak, A ;
Steck, S ;
Graf, M ;
Wild, J ;
Schirmbeck, R ;
Wolf, H ;
Wagner, R .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10991-11001